Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer-Reference-Cited by-同舟云学术

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer

Published:2017-06 Issue:6 Volume:71 Page:961-969
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Christensen Emil,Birkenkamp-Demtröder Karin,Nordentoft Iver,Høyer Søren,van der Keur Kirstin,van Kessel Kim,Zwarthoff Ellen,Agerbæk Mads,Ørntoft Torben Falck,Jensen Jørgen Bjerggaard,Dyrskjøt Lars

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Babjuk M, Böhle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 2017;71:447–61.

3. Bladder cancer: epidemiology, staging and grading, and diagnosis;Kirkali;Urology,2005

4. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure;Stein;World J Urol,2006

5. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker;Current Opinion in Urology;2024-09-04

2. High sensitivity ctDNA assays in genitourinary malignancies: current evidence and future directions;The Oncologist;2024-08-02

3. Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications;Cancers;2024-06-20

4. From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer;Current Oncology Reports;2024-06-05

5. Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict Neoadjuvant Therapy Efficacy in Bladder Cancer;Clinical Genitourinary Cancer;2024-06